Biotech ETFs To Suffer As US Backs IP Waiver For COVID-19 Vaccines
May 08, 2021 at 19:01 PM EDT
The Biden administration announced support for the waiver of intellectual property protections for COVID-19 vaccines proposed by South Africa and India. Let’s take a look at ETFs that can suffer from the recent development:
